BPC – 157 (10mg)

$75.00

BPC-157 is a synthetic 15-amino-acid peptide, originally identified in gastric juice, studied in preclinical models for tissue repair, angiogenesis and inflammation signalling. Supplied as a 10 mg lyophilised vial for laboratory research use only.

Description

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a research-grade, synthetic 15-amino-acid peptide originally identified in human gastric juice and later synthesized for laboratory studies. Unlike many endocrine-related peptides, it is primarily examined for its potential in tissue repair, inflammation modulation, and protective mechanisms across multiple organ systems.

Chemical structure of BPC-157

This pentadecapeptide has the sequence Gly–Glu–Pro–Pro–Pro–Gly–Lys–Pro–Ala–Asp–Asp–Ala–Gly–Leu–Val, with a molecular formula of C₆₂H₉₈N₁₆O₂₂ and a molecular weight of approximately 1,419.5 Da. It is stable at room temperature and demonstrates resilience in gastric conditions, making it viable for various routes of administration in experimental models.

What are the effects of BPC-157?

  • Tissue regeneration and wound healing: preclinical studies in rodents report accelerated healing of tendons, ligaments, skin wounds, and muscle injuries, correlating with increased fibroblast growth, collagen synthesis, and angiogenesis.
  • Gastrointestinal protection: demonstrated anti-ulcer and cytoprotective effects in gastric injury models, with regulated villus-crypt structure and intestinal tissue preservation.
  • Angiogenesis and vascular repair: stimulates vascular endothelial growth factor (VEGF) signaling and nitric oxide pathways, promoting blood vessel formation in ischemic and injury models.
  • Neuro- and organ-protection: experimental findings suggest BPC-157 mitigates brain and nerve injury, maintains liver and kidney integrity under toxic stress, and reduces inflammatory markers.
  • Anti-inflammatory and oxidative stress reduction: modulates nitric oxide and inflammatory cytokines, displaying both antioxidant and analgesic effects in animal research.
  • Safety profile: to date, studies report low toxicity and no significant adverse immunogenic or endocrine reactions under laboratory conditions.

Citations

  • PubChem, “BPC-157 Compound Summary,” NCBI PubChem, CID 9941957.
  • Peptide Sciences, “What is BPC-157 Peptide?”
  • Seiwerth S, et al. “Stable Gastric Pentadecapeptide BPC-157 and Wound Healing.” Front Pharmacol. 2021;12:627533.
  • Staresinic M, et al. “BPC-157 accelerates healing of rat Achilles tendon.” J Orthop Res. 2003;21(6):976–983.
  • Chang CH, et al. “BPC-157 promotes tendon healing.” J Appl Physiol. 2011;110(3):774–780.
  • “Stable gastric pentadecapeptide BPC-157: GI therapy.” Curr Pharm Des. 2011.
  • “BPC-157 promotes angiogenesis via VEGFR2 and NO.”
  • Cerovecki T, et al. “BPC-157 improves ligament healing in rats.” J Orthop Res. 2010;28(9):1155–1161.

This product is supplied for laboratory research use only. Most evidence comes from animal studies and early-stage research.

Research Use Only
This product is sold exclusively as a research chemical for in-vitro laboratory investigation by qualified researchers. It is not a drug, not a dietary supplement, and not intended for human or veterinary consumption, diagnostic use, or any form of therapeutic application. No statement on this page should be read as medical advice or as a claim that this compound treats, prevents, or cures any condition. Findings referenced above are drawn from published preclinical and clinical literature and are provided for scientific reference only.

Reviews

There are no reviews yet.

Be the first to review “BPC – 157 (10mg)”

Your email address will not be published. Required fields are marked *